Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017877 |
---|---|
Receipt number | R000020713 |
Scientific Title | First-line afatinib in patients aged 75 or older with advanced non-squamous non-small cell lung cancer harboring EGFR mutations; non-randomized phase II trial |
Date of disclosure of the study information | 2015/08/01 |
Last modified on | 2021/06/15 10:32:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/06/11 17:25:21 | ||
2 | Update | 2015/09/17 17:32:38 | Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2015/09/17 17:33:56 | Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2017/06/12 10:33:48 | Recruitment status |
|
5 | Update | 2017/12/14 11:44:25 | Name of primary person or sponsor Organization |
|
6 | Update | 2017/12/14 11:46:17 | Recruitment status Last follow-up date |
|
7 | Update | 2019/06/17 11:45:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/06/17 12:18:21 | Number of participants that the trial has enrolled Results Results Results date posted |
|
9 | Update | 2019/06/17 12:24:41 | Date of IRB |
|
10 | Update | 2021/06/15 10:32:23 | Recruitment status |